☆ 4.5 Article

Seizure-Associated Genes Acrosss Species database offers insights into epilepsy genes, pathways, and treatments

EPILEPSIA (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

A retrospective analysis of memantine use in a pediatric neurology clinic

Sarah Bouhadoun et al.

Summary: Memantine, an NMDA receptor antagonist, is generally well-tolerated in children and may have potential benefit for a broad range of pediatric neurodevelopmental disorders. In a single-center pediatric neurology clinic, 8 children were treated with memantine for conditions including developmental and epileptic encephalopathy, ASD, and ADHD. The study found clear cognitive improvement in some patients and a reduction in seizure frequency in a girl with a GRIN2A variant of uncertain significance.

BRAIN & DEVELOPMENT (2021)

Add to Collection

Article Behavioral Sciences

Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations

Mary E. Moya-Mendez et al.

Summary: ATP1A2 mutations can cause early-onset severe epileptic encephalopathy, leading to symptoms such as drug-resistant seizures and developmental delay. Memantine therapy, an NMDA receptor antagonist, showed tolerability and some improvements in patients with ATP1A2 mutations. Future studies on NMDAR antagonist therapy in ATP1A2-encephalopathy are warranted.

EPILEPSY & BEHAVIOR (2021)

Add to Collection

Article Clinical Neurology

Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy

Yuchen Xu et al.

Summary: A variant in the GRIN1 gene was identified in a patient with epilepsy, leading to enhanced agonist potency and sensitivity to certain FDA-approved drugs, ultimately reducing seizure burden. This finding contributes to the understanding of genotype-phenotype correlations and explores therapeutic strategies for treating GRIN1-related neurological conditions.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Using common genetic variants to find drugs for common epilepsies

Nasir Mirza et al.

Summary: Researchers have developed a novel genomic method to predict the relative efficacy of drugs for treating common epilepsies, offering a new resource for selecting suitable candidate drugs to be repurposed.

BRAIN COMMUNICATIONS (2021)

Add to Collection

Article Biochemical Research Methods

hypeR: an R package for geneset enrichment workflows

Anthony Federico et al.

BIOINFORMATICS (2020)

Add to Collection

Review Public, Environmental & Occupational Health

The Epidemiology of Epilepsy

Ettore Beghi

NEUROEPIDEMIOLOGY (2020)

Add to Collection

Article Clinical Neurology

Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons

Andrew M. Tidball et al.

BRAIN (2020)

Add to Collection

Article Clinical Neurology

The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy

Shayeeshan Sivapalarajah et al.

EPILEPSIA (2018)

Add to Collection

Review Neurosciences

What do genetic studies tell us about the heritable basis of common epilepsy? Polygenic or complex epilepsy?

Bobby P. C. Koeleman

NEUROSCIENCE LETTERS (2018)

Add to Collection

Article Pediatrics

Clinical Benefit of NMDA Receptor Antagonists in a Patient With ATP1A2 Gene Mutation

Keisuke Ueda et al.

PEDIATRICS (2018)

Add to Collection

Article Clinical Neurology

Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study

Zhibin Chen et al.

JAMA NEUROLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies

Bassel Abou-Khalil et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Critical Care Medicine

Verapamilas an Adjuvant Treatmentor Drug-Resistant Epilepsy

S. Lakshmikanthcharan et al.

INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2018)

Add to Collection

Review Clinical Neurology

Epilepsy-associated genes

Jie Wang et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)

Add to Collection

Article Clinical Neurology

Low dose verapamil as an adjunct therapy for medically refractory epilepsy - An open label pilot study

Jaishree Narayanan et al.

EPILEPSY RESEARCH (2016)

Add to Collection

Article Biochemistry & Molecular Biology

EpilepsyGene: a genetic resource for genes and mutations related to epilepsy

Xia Ran et al.

NUCLEIC ACIDS RESEARCH (2015)

Add to Collection

Article Clinical Neurology

Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: A pilot study

Francesco Nicita et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2014)

Add to Collection

Article Behavioral Sciences

Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: A pilot study

Ali A. Asadi-Pooya et al.

EPILEPSY & BEHAVIOR (2013)

Add to Collection

Article Multidisciplinary Sciences

VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures

Litsa Nikitidou et al.

PLOS ONE (2012)

Add to Collection

Article Behavioral Sciences

Verapamil attenuates the malignant treatment course in recurrent status epilepticus

Friedhelm C. Schmitt et al.

EPILEPSY & BEHAVIOR (2010)

Add to Collection

Article Clinical Neurology

Adverse antiepileptic drug effects Toward a clinically and neurobiologically relevant taxonomy

Piero Perucca et al.

NEUROLOGY (2009)

Add to Collection

Article Clinical Neurology

Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus

P Iannetti et al.

EPILEPSIA (2005)

Add to Collection

Article Pharmacology & Pharmacy

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy

MA Summers et al.

ANNALS OF PHARMACOTHERAPY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.